 WALTHAM, Mass., Sept. 22, 2022 GLOBE NEWSWIRE -- Xilio Therapeutics, Inc. Nasdaq: XLO, a biotechnology company developing tumor-selective immuno-oncology therapies for people living with cancer, today announced that the company will participate in a fireside chat at the Guggenheim Nantucket Therapeutics Conference on Thursday, September 29, 2022, at 10:15 a.m. ET. 